Project Grant HT94252410586
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The federal Project Grant award of $319,624 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Oregon Health & Science University (OHSU) located in Portland, Oregon. The award supports advanced biomedical research aimed at investigating cell cycle regulators in oligodendrocyte myelination, which is relevant to transforming healthcare for military service members and the broader public. OHSU, a prominent academic...
This federal Project Grant award of $1,525,292 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project led by Oregon Health & Science University (OHSU) to characterize the progression of prostate cancer through integrated analysis of single-cell data. The project, which commenced on September 30, 2024 and is scheduled for completion by September 29, 2027, aims to advance the understanding of prostate cancer biology and...
The Defense Health Agency awarded a $472,251.00 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development program (CFDA 12.420) to identify novel compounds for the treatment of pPDAchordoma and other SMARCB1-deficient rare tumors. The award period is from August 1, 2023 to July 31, 2026. Through this grant, OHSU will conduct research and development activities to discover and evaluate new drug compounds that could potentially treat these...
Oregon Health & Science University was awarded a $494,340 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The federal Project Grant award of $161,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Duke University to investigate breast cancer brain metastases. The research aims to integrate immunogenomic and phenotypic vulnerabilities to improve outcomes for this challenging condition. The award period runs from April 1, 2025 to March 31, 2026. This grant is part of the Defense Health Agency's strategic...
The Department of Defense's Defense Health Agency awarded a $699,726 Project Grant to The Washington University Office of Sponsored Research Services Division in St. Louis, Missouri. The grant, titled "BEYOND BREAST DENSITY: NOVEL CLINICALLY RELEVANT RISK MEASURES FOR BREAST CANCER IN BLACK WOMEN," is funded through the Military Medical Research and Development program (CFDA 12.420) and will run from February 1, 2024 to January 31, 2026. This federal grant supports biomedical...
The Defense Health Agency has awarded a $862,751 Project Grant to the University of Wisconsin-Milwaukee (UWM) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective June 1, 2024 through May 31, 2027, will fund a research project to study the "Impact of Recent Childbirth on Breast Cancer Prognosis and Tumor Molecular Phenotypes Among Young Black and White Women." This grant supports UWM's ongoing biomedical research initiatives focused on...
Oregon Health & Science University was awarded a $385,000 project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The two-year grant will support research to investigate the molecular and biological contributions of the SMARCA4 tumor suppressor gene to the formation of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). Through basic and applied medical research, the Military Medical Research and Development...
The Baylor College of Medicine will use a $1.6 million Project Grant from the Defense Health Agency to research germline variants and population-wide breast cancer risk. The grant was awarded on February 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through basic, applied, and advanced biomedical research, this project aims to transform healthcare for service members and the public by investigating medical solutions for the battlefield and developing...
Oregon Health & Science University was awarded a $506,554 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 through July 2025 to elucidate mechanisms of rapid metastatic recurrence in pancreatic ductal adenocarcinoma. Through basic, applied, and advanced biomedical research supported by this program, the Army aims to transform military and public health care by...